Clinical characteristics and associations with EpCAMmRNA+ CTCs and Treg/CD4+ were analyzed using the χ 2 test and the t-test for two subgroups of HCC patients according to the calculated cut-off values (Tables 2 and 3). Here, CD4 is linked to hepatocellular carcinoma.